Zacks Research Issues Pessimistic Forecast for THC Earnings

Tenet Healthcare Co. (NYSE:THC - Free Report) - Analysts at Zacks Research reduced their Q4 2024 EPS estimates for Tenet Healthcare in a research note issued to investors on Wednesday, December 18th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $2.87 for the quarter, down from their previous forecast of $2.88. The consensus estimate for Tenet Healthcare's current full-year earnings is $11.38 per share. Zacks Research also issued estimates for Tenet Healthcare's Q2 2025 earnings at $2.66 EPS, Q4 2025 earnings at $3.20 EPS and Q1 2026 earnings at $3.45 EPS.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.93 earnings per share for the quarter, topping the consensus estimate of $2.33 by $0.60. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%. The firm had revenue of $5.12 billion during the quarter, compared to analysts' expectations of $5.05 billion. During the same quarter in the previous year, the business earned $1.44 earnings per share. The company's revenue was up 1.1% on a year-over-year basis.

Several other brokerages have also recently issued reports on THC. StockNews.com cut shares of Tenet Healthcare from a "strong-buy" rating to a "buy" rating in a report on Tuesday, December 17th. UBS Group lifted their price objective on Tenet Healthcare from $197.00 to $217.00 and gave the stock a "buy" rating in a report on Wednesday, October 30th. Cantor Fitzgerald increased their target price on Tenet Healthcare from $168.00 to $177.00 and gave the company an "overweight" rating in a report on Wednesday, October 30th. Barclays upped their price target on shares of Tenet Healthcare from $171.00 to $190.00 and gave the company an "overweight" rating in a research report on Friday, November 8th. Finally, Wells Fargo & Company downgraded shares of Tenet Healthcare from an "overweight" rating to an "equal weight" rating and dropped their price objective for the stock from $205.00 to $150.00 in a report on Monday, November 25th. Three analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, Tenet Healthcare has an average rating of "Moderate Buy" and an average price target of $166.88.

Tenet Healthcare Stock Performance

Shares of NYSE THC traded up $0.18 during trading on Monday, reaching $129.64. 1,117,957 shares of the company traded hands, compared to its average volume of 1,252,680. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 2.35. The firm has a 50 day simple moving average of $149.74 and a 200-day simple moving average of $149.24. Tenet Healthcare has a 52-week low of $73.21 and a 52-week high of $171.20. The stock has a market capitalization of $12.33 billion, a PE ratio of 4.15, a P/E/G ratio of 0.61 and a beta of 2.06.

Insider Transactions at Tenet Healthcare

In other news, EVP Lisa Y. Foo sold 4,000 shares of the business's stock in a transaction on Thursday, October 31st. The shares were sold at an average price of $155.94, for a total value of $623,760.00. Following the transaction, the executive vice president now owns 15,566 shares of the company's stock, valued at approximately $2,427,362.04. The trade was a 20.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.93% of the company's stock.

Institutional Trading of Tenet Healthcare

Several hedge funds have recently bought and sold shares of the stock. Legacy Capital Group California Inc. bought a new stake in shares of Tenet Healthcare in the third quarter worth about $1,055,000. Caprock Group LLC purchased a new stake in shares of Tenet Healthcare during the 2nd quarter worth approximately $477,000. Intech Investment Management LLC grew its holdings in shares of Tenet Healthcare by 44.4% in the third quarter. Intech Investment Management LLC now owns 79,266 shares of the company's stock valued at $13,174,000 after purchasing an additional 24,385 shares in the last quarter. Swiss National Bank increased its position in Tenet Healthcare by 8.7% in the third quarter. Swiss National Bank now owns 190,800 shares of the company's stock worth $31,711,000 after purchasing an additional 15,200 shares during the last quarter. Finally, Estate Counselors LLC bought a new position in Tenet Healthcare during the third quarter valued at $1,792,000. Hedge funds and other institutional investors own 95.44% of the company's stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.